Results 221 to 230 of about 132,133 (266)
Some of the next articles are maybe not open access.

Inherited interstitial lung disease

Clinics in Chest Medicine, 2004
This article focuses on recent advances in the identification of genes and genetic polymorphisms that have been implicated in the development of human interstitial lung diseases. It focuses on the inherited mendelian diseases in which pulmonary fibrosis is part of the clinical phenotype and the genetics of familial idiopathic pulmonary fibrosis and ...
Christine Kim, Garcia, Ganesh, Raghu
openaire   +2 more sources

Interstitial lung disease

The Indian Journal of Pediatrics, 1996
Interstitial lung disease in children is a complex group of disorders whose etiology and pathogenesis is not entirely clear. Although the basic pathogenesis has been extrapolated from adult studies, its relevance in the pediatric population can be questioned.
openaire   +2 more sources

Occupational interstitial lung disease

Clinics in Chest Medicine, 2004
Occupational interstitial lung diseases are a diverse group of disorders of varied cause. Occupational causes account for a significant portion of all interstitial lung diseases, and new causes continue to be described. Although some are diseases of antiquity, they continue to occur in the workplace and often are misdiagnosed as "idiopathic" when ...
Craig S, Glazer, Lee S, Newman
openaire   +2 more sources

Imaging of Interstitial Lung Disease

Radiologic Clinics of North America, 2004
This article provides a comprehensive summary of typical imaging features of common interstitial lung diseases with an emphasis on high-resolution computed tomography (HRCT). The classification of interstitial lung disease that is used is in accordance with the consensus statement of the American Thoracic Society.
Sudhakar, Pipavath, J David, Godwin
openaire   +2 more sources

Eosinophilic interstitial lung disease

Current Opinion in Pulmonary Medicine, 2004
Although rare, the eosinophilic lung diseases are being increasingly identified as distinct clinical entities. These disorders are a heterogeneous group of disorders in which there is an increased number of eosinophils in the airways and/or lung parenchyma.
openaire   +2 more sources

Lung transplantation for interstitial lung disease

Clinics in Chest Medicine, 2004
Lung transplantation remains the only therapeutic option shown to improve survival for many end-stage interstitial lung diseases. Although idiopathic pulmonary fibrosis is the most common indication, transplantation has been performed for many other diseases.
Brandon S, Lu, Sangeeta M, Bhorade
openaire   +2 more sources

Interstitial Lung Disease and Lung Transplantation

Seminars in Respiratory and Critical Care Medicine, 2010
Idiopathic pulmonary fibrosis (IPF) is the most common of the idiopathic interstitial pneumonias and carries the worst prognosis. Currently the best treatment option is lung transplantation. Historically patients with IPF had poor outcomes following referral for lung transplant due to high waiting-list mortality. The introduction of the lung allocation
Sarah, O'Beirne   +2 more
openaire   +2 more sources

Lung transplantation in interstitial lung disease

Current Opinion in Pulmonary Medicine, 2001
Interstitial lung disease is a heterogeneous group of illnesses, some of which may progress to a fibrosing stage and cause respiratory failure. For selected candidates, lung transplantation is the ultimate therapeutic option. We review data on lung transplantation for various interstitial lung diseases.
R, Sulica, A, Teirstein, M L, Padilla
openaire   +2 more sources

Lung transplantation and interstitial lung disease

Current Opinion in Pulmonary Medicine, 2005
Interstitial lung disease includes a heterogeneous group of disorders that leads to respiratory insufficiency and death in a significant number of patients. Lung transplantation is a therapeutic option in select candidates.The indications, transplant procedure options, and outcomes continue to evolve.
Raed, Alalawi   +3 more
openaire   +2 more sources

[Interstitial lung disease].

Deutsche medizinische Wochenschrift (1946), 2011
This concise article summarizes recent advances in the field of interstitial lung disease (ILD) with particular focus on clinically relevant findings. As a novel treatment option for idiopathic pulmonary fibrosis (IPF), pirfenidone has been granted marketing authorization in the European Union for the treatment of mild to moderate IPF. In contrast, the
D, von der Beck, A, Günther, P, Markart
openaire   +2 more sources

Home - About - Disclaimer - Privacy